<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-R8R4R5X0</identifier><date>2013</date><creator>Kerec Kos, Mojca</creator><relation>documents/doc/R/URN_NBN_SI_doc-R8R4R5X0_001.htm</relation><relation>documents/doc/R/URN_NBN_SI_doc-R8R4R5X0_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-R8R4R5X0_001.txt</relation><format format_type="issue">2</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 118-123</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3472497</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-R8R4R5X0</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">glukozamin</subject><subject language_type_id="slv">osteoartritis</subject><subject language_type_id="slv">osteoartroza</subject><title>Glucosamine - a critical review of its efficacy and bioavailability</title><title>Glukozamin - kritičen pogled z vidika delovanja in biološke uporabnosti</title></Record>